Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function - PubMed (original) (raw)
Comparative Study
Neurofibrillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function
David A Bennett et al. Arch Neurol. 2004 Mar.
Abstract
Objective: To test the hypothesis that the association of amyloid load with clinical Alzheimer disease (AD) and cognitive impairment is mediated through neurofibrillary tangles.
Design: Longitudinal clinicopathologic cohort study.
Participants and setting: Forty-four individuals with clinically diagnosed AD and 53 without dementia who participated in the Religious Orders Study underwent a uniform structured clinical evaluation for AD and cognitive testing about 8 months prior to death, and brain autopsy at death.
Methods: The percent area occupied by amyloid-beta and the density of neurofibrillary tangles were quantified from 6 brain regions and averaged to yield summary measures of amyloid load and neurofibrillary tangles. Multivariate regression analyses were used to simultaneously examine the effects of amyloid load and neurofibrillary tangles on clinically diagnosed AD and level of cognition.
Main outcome measures: Clinically diagnosed AD and level of global cognitive function proximate to death.
Results: In separate logistic regression analyses, each 1% increase in amyloid load was associated with about a 50% increase in the odds of clinical AD (P =.002), and each neurofibrillary tangle was associated with a greater than 20% increase in the odds of clinical AD (P<.001). When a term for tangles was added to the regression model with amyloid, the association of amyloid load with clinical disease was reduced by more than 60% and was no longer significant, whereas the association of tangles with clinical disease was essentially unchanged. Similar results were found in analyses of global cognitive function.
Conclusion: These findings are consistent with a sequence of pathologic events whereby the effect of amyloid deposition on clinical disease is mediated by neurofibrillary tangles.
Similar articles
- Sex differences in the clinical manifestations of Alzheimer disease pathology.
Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Barnes LL, et al. Arch Gen Psychiatry. 2005 Jun;62(6):685-91. doi: 10.1001/archpsyc.62.6.685. Arch Gen Psychiatry. 2005. PMID: 15939846 - Diabetes is related to cerebral infarction but not to AD pathology in older persons.
Arvanitakis Z, Schneider JA, Wilson RS, Li Y, Arnold SE, Wang Z, Bennett DA. Arvanitakis Z, et al. Neurology. 2006 Dec 12;67(11):1960-5. doi: 10.1212/01.wnl.0000247053.45483.4e. Neurology. 2006. PMID: 17159101 - Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL, Weintraub S, Mash DC, Mesulam MM. Guillozet AL, et al. Arch Neurol. 2003 May;60(5):729-36. doi: 10.1001/archneur.60.5.729. Arch Neurol. 2003. PMID: 12756137 - Assessing the cognitive impact of Alzheimer disease pathology and vascular burden in the aging brain: the Geneva experience.
Giannakopoulos P, Gold G, Kövari E, von Gunten A, Imhof A, Bouras C, Hof PR. Giannakopoulos P, et al. Acta Neuropathol. 2007 Jan;113(1):1-12. doi: 10.1007/s00401-006-0144-y. Epub 2006 Oct 12. Acta Neuropathol. 2007. PMID: 17036244 Review. - Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia.
Ferrer I. Ferrer I. Prog Neurobiol. 2012 Apr;97(1):38-51. doi: 10.1016/j.pneurobio.2012.03.005. Epub 2012 Mar 21. Prog Neurobiol. 2012. PMID: 22459297 Review.
Cited by
- Overview and findings from the religious orders study.
Bennett DA, Schneider JA, Arvanitakis Z, Wilson RS. Bennett DA, et al. Curr Alzheimer Res. 2012 Jul;9(6):628-45. doi: 10.2174/156720512801322573. Curr Alzheimer Res. 2012. PMID: 22471860 Free PMC article. - Braak stage and trajectory of cognitive decline in noncognitively impaired elders.
Mufson EJ, Malek-Ahmadi M, Snyder N, Ausdemore J, Chen K, Perez SE. Mufson EJ, et al. Neurobiol Aging. 2016 Jul;43:101-10. doi: 10.1016/j.neurobiolaging.2016.03.003. Epub 2016 Mar 10. Neurobiol Aging. 2016. PMID: 27255819 Free PMC article. - Cell-type-specific Alzheimer's disease polygenic risk scores are associated with distinct disease processes in Alzheimer's disease.
Yang HS, Teng L, Kang D, Menon V, Ge T, Finucane HK, Schultz AP, Properzi M, Klein HU, Chibnik LB, Schneider JA, Bennett DA, Hohman TJ, Mayeux RP, Johnson KA, De Jager PL, Sperling RA. Yang HS, et al. Nat Commun. 2023 Nov 30;14(1):7659. doi: 10.1038/s41467-023-43132-2. Nat Commun. 2023. PMID: 38036535 Free PMC article. - Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease.
Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM. Uddin MS, et al. Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858. Int J Mol Sci. 2020. PMID: 32824102 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical